111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024

Rhea-AI Summary

111, Inc. (NASDAQ: YI) has announced its participation in a fireside chat with Water Tower Research on December 6, 2024 at 11:00 a.m. ET. The company's Co-Founder, Chairman, and CEO, Junling Liu, will discuss Q3 2024 earnings (to be reported on November 27, 2024), along with challenges, opportunities, and NASDAQ share price compliance issues. The tech-enabled healthcare platform company, focused on digitally transforming China's healthcare value chain, will host this listen-only event with WTR's senior research analyst Robert Sassoon. A replay will be available on 111's investor relations website.

News Market Reaction

+0.69%

1 alert

+0.69% News Effect

On the day this news was published, YI gained 0.69%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SHANGHAI, Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Friday, December 6, 2024 at 11:00 a.m. ET.

Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q3 2024 earnings (to be reported on Wednesday, November 27, 2024), along with challenges, opportunities, and the NASDAQ share price compliance issue.

To register for this listen-only event, please visit:

Fireside Chat Registration Link

The replay of the fireside chat will be available under "Events" in the 111's investor relations website at http://ir.111.com.cn/.

Forward-Looking Statements

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Among other things, the Business Outlook and quotations from management in this announcement, as well as 111's strategic and operational plans, contain forward-looking statements. 111 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company's ability comply with extensive and evolving regulatory requirements, its ability to compete effectively in the evolving PRC general health and wellness market, its ability to manage the growth of its business and expansion plans, its ability to achieve or maintain profitability in the future, its ability to control the risks associated with its pharmaceutical retail and wholesale businesses, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and 111 does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/.

View original content:https://www.prnewswire.com/news-releases/111-inc-to-participate-in-fireside-chat-with-water-tower-research-on-december-6-2024-302312552.html

SOURCE 111, Inc.

FAQ

When will 111, Inc. (YI) report its Q3 2024 earnings?

111, Inc. will report its Q3 2024 earnings on Wednesday, November 27, 2024.

What time is 111, Inc.'s (YI) fireside chat with Water Tower Research?

The fireside chat is scheduled for December 6, 2024, at 11:00 a.m. ET.

What topics will be discussed in 111, Inc.'s (YI) December 2024 fireside chat?

The discussion will cover Q3 2024 earnings, challenges, opportunities, and the NASDAQ share price compliance issue.

Where can I watch the replay of 111, Inc.'s (YI) December 2024 fireside chat?

The replay will be available under the 'Events' section on 111's investor relations website at http://ir.111.com.cn/.